Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
6.28
+0.42 (7.17%)
Dec 20, 2024, 4:00 PM EST - Market closed
Enanta Pharmaceuticals Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $133.10 million as of December 20, 2024. Its market cap has decreased by -33.32% in one year.
Market Cap
133.10M
Enterprise Value
110.97M
1-Year Change
-33.32%
Ranking
Category
Stock Price
$6.28
Market Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has decreased from $289.30M to $133.10M, a decrease of -53.99%. That is a compound annual growth rate of -6.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 133.10M | -32.85% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 128.12M |
| Akoya Biosciences | 126.39M |
| Monopar Therapeutics | 125.56M |
| Galectin Therapeutics | 125.52M |
| InflaRx | 125.42M |
| Black Diamond Therapeutics | 123.92M |
| Atossa Therapeutics | 123.29M |
| Elutia | 122.00M |